Article
Differential oncogenic potential of activated RAS isoforms in melanocytes.
Oncogene - 5 Jul 2007
Whitwam T, Vanbrocklin M W, Russo M E, Haak P T, Bilgili D, Resau J H, Koo H-M, Holmen S L
Abstract excerpt
RAS genes are mutated in approximately 30% of all human cancers. Interestingly, there exists a strong bias in favor of mutation of only one of the three major RAS genes in tumors of different cellular origins. NRAS mutations occur in approximately 20% of human melanomas, whereas HRAS and KRAS mutations are rare in this disease. To define the mechanism(s) responsible for this preference in melanocytes, we compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.